ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,836Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 569

$635K Total Retail Price of All Prescriptions

Rank: 12 out of 569

528 Patients Receiving at Least One Drug in Part D
80% Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 812 660 151 1 1
SIMVASTATIN 417 334 87 2 3
LISINOPRIL 412 309 85 3 2
OMEPRAZOLE 400 285 83 4 4
FUROSEMIDE 385 314 72 5 11
POTASSIUM CHLORIDE 329 266 64 6 26
HYDROCODONE-ACETAMINOPHEN 272 178 75 S3 7 7
METFORMIN HCL 270 192 64 8 5
SERTRALINE HCL 251 208 42 9 20
AMLODIPINE BESYLATE 222 177 43 10 6
ATENOLOL 217 185 44 11 19
GABAPENTIN 204 127 48 12 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 151 43 13 21
METOPROLOL TARTRATE 171 146 30 14 14
ATORVASTATIN CALCIUM 168 122 30 15 10
CLOPIDOGREL 168 163* 30 15 34
WARFARIN SODIUM 163 130 30 17 27
METOPROLOL SUCCINATE 144 132 24 18 15
DONEPEZIL HCL 142 137* 21 19 43
LANTUS 135 108 23 20 46
HYDROCHLOROTHIAZIDE 133 103 27 21 8
NAMENDA 127 110 14 22 51
MELOXICAM 127 62 26 22 40
TRAMADOL HCL 114 88 34 24 25
GLYBURIDE 111 82 24 R 25 74
ALENDRONATE SODIUM 108 95 17 26 16
ALLOPURINOL 106 101* 22 27 37
CARVEDILOL 104 91 23 28 38
LOVASTATIN 103 84 22 29 12
PREDNISONE 91 57 39 30 45
TRIAMTERENE-HCTZ 89 76 16 31 54
CEPHALEXIN 84 79* 52 32 80
TEMAZEPAM 81 49 22 B 33 107
PANTOPRAZOLE SODIUM 80 75* 17 34 36
ALPRAZOLAM 80 43 29 B 34 28
NITROFURANTOIN* 78 45 17 36 184
SYNTHROID 75 70* 21 37 64
PROPRANOLOL HCL 71 66* 14 38 120
PROAIR HFA 70 22 24 39 30
OXYCODONE HCL-ACETAMINOPHEN 68 16 17 S2 40 56
RISPERIDONE 67 67 12 A 41 102
DIOVAN 63 63 11 42 61
LOSARTAN POTASSIUM 63 52 14 42 13
ENALAPRIL MALEATE 63 <11 <11 42 76
AZITHROMYCIN 62 38 38 45 44
TAMSULOSIN HCL 57 <11 <11 46 22
CYMBALTA 56 <11 <11 47 66
GLIPIZIDE 56 51* 11 47 35
FINASTERIDE 56 <11 <11 47 57
RANITIDINE HCL 55 35 13 50 29
PIOGLITAZONE HCL 55 <11 <11 R 50 82
PAROXETINE HCL 55 41 12 50 55
OXYCODONE HCL 53 <11 <11 S2 53 31
METOCLOPRAMIDE HCL 51 46* 20 54 139
CARBIDOPA-LEVODOPA 50 30 16 55 145
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.